Retrotope

4300 El Camino Real
Suite 201
Los Altos
California
94022
United States

Tel: 650-917-9256

Email: info@retrotope.com

Show jobs for this employer

About Retrotope

Retrotope has created a new category of drug platform to preserve and restore mitochondrial health in degenerative diseases. The unique mechanism of Retrotope’s platform prevents cellular damage and recovers cellular function damaged by lipid peroxidation due to oxidative stress. Retrotope’s first product candidate, RT001, is being clinically tested in Friedreich’s ataxia (FA), a high value untreated fatal orphan disease. Retrotope’s transformational platform technology of stabilized lipid drugs has the potential to treat a wide variety of other mitochondrial myopathies, but also show promise for diseases such as Parkinson’s, Alzheimer’s, diabetic retinopathy, and others.
YEAR FOUNDED:
2006
LEADERSHIP:
Founder and CEO: Robert J. Molinari
Founder and CSO: Mikhail S. Shchepinov
JOBS:
Please click here for Retrotope job opportunities.

13 articles with Retrotope